119 related articles for article (PubMed ID: 15680433)
41. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.
Inoshima Y; Kohmoto M; Ikeda Y; Yamada H; Kawaguchi Y; Tomonaga K; Miyazawa T; Kai C; Umemura T; Mikami T
J Virol; 1996 Dec; 70(12):8518-26. PubMed ID: 8970975
[TBL] [Abstract][Full Text] [Related]
42. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Zwijnenberg R; Yamamoto JK
Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
[No Abstract] [Full Text] [Related]
43. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
Yamamoto JK; Pu R; Sato E; Hohdatsu T
AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517
[No Abstract] [Full Text] [Related]
44. During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.
Bendinelli M; Pistello M; Del Mauro D; Cammarota G; Maggi F; Leonildi A; Giannecchini S; Bergamini C; Matteucci D
J Virol; 2001 May; 75(10):4584-93. PubMed ID: 11312328
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of subunit vaccines against feline immunodeficiency virus infection.
Verschoor EJ; Willemse MJ; Stam JG; van Vliet AL; Pouwels H; Chalmers SK; Horzinek MC; Sondermeijer PJ; Hesselink W; de Ronde A
Vaccine; 1996 Mar; 14(4):285-9. PubMed ID: 8744554
[TBL] [Abstract][Full Text] [Related]
46. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors.
Li Z; Phadke A; Weaver EA; Ball JM; Collisson EW
Dev Comp Immunol; 2005; 29(9):809-24. PubMed ID: 15936436
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia.
Norris JM; Bell ET; Hales L; Toribio JA; White JD; Wigney DI; Baral RM; Malik R
J Feline Med Surg; 2007 Aug; 9(4):300-8. PubMed ID: 17409007
[TBL] [Abstract][Full Text] [Related]
49. Effects of an oral superoxide dismutase enzyme supplementation on indices of oxidative stress, proviral load, and CD4:CD8 ratios in asymptomatic FIV-infected cats.
Webb CB; Lehman TL; McCord KW
J Feline Med Surg; 2008 Oct; 10(5):423-30. PubMed ID: 18387839
[TBL] [Abstract][Full Text] [Related]
50. Glycan moiety modifications of feline alpha1-acid glycoprotein in retrovirus (FIV, FeLV) affected cats.
Pocacqua V; Provasi E; Paltrinieri S; Gelain E; Comunian C; Ceciliani F
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):17-26. PubMed ID: 15982476
[TBL] [Abstract][Full Text] [Related]
51. Early pathological changes in the central nervous system of acutely feline-immunodeficiency-virus-infected cats.
Hein A; Martin JP; Dörries R
Virology; 2005 Dec; 343(2):162-70. PubMed ID: 16168453
[TBL] [Abstract][Full Text] [Related]
52. Phylogenetic analysis of Portuguese Feline Immunodeficiency Virus sequences reveals high genetic diversity.
Duarte A; Tavares L
Vet Microbiol; 2006 Apr; 114(1-2):25-33. PubMed ID: 16384661
[TBL] [Abstract][Full Text] [Related]
53. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
[TBL] [Abstract][Full Text] [Related]
54. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
Kahler SC;
J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
[No Abstract] [Full Text] [Related]
55. Feline cytokine ELISPOT: issues in assay development.
Nordone SK; Stevens R; LaVoy AS; Dean GA
Methods Mol Biol; 2005; 302():167-78. PubMed ID: 15937351
[TBL] [Abstract][Full Text] [Related]
56. The roles of vif and ORF-A genes and AP-1 binding site in in vivo replication of feline immunodeficiency virus.
Inoshima Y; Miyazawa T; Mikami T
Arch Virol; 1998; 143(4):789-95. PubMed ID: 9638148
[TBL] [Abstract][Full Text] [Related]
57. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
[TBL] [Abstract][Full Text] [Related]
58. Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein.
Giannecchini S; Alcaro MC; Isola P; Sichi O; Pistello M; Papini AM; Rovero P; Bendinelli M
Antivir Ther; 2005; 10(5):671-80. PubMed ID: 16152761
[TBL] [Abstract][Full Text] [Related]
59. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.
Dean GA; LaVoy A; Yearley J; Stanton C
J Infect Dis; 2006 Jun; 193(11):1520-7. PubMed ID: 16652280
[TBL] [Abstract][Full Text] [Related]
60. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection.
Hartmann K; Griessmayr P; Schulz B; Greene CE; Vidyashankar AN; Jarrett O; Egberink HF
J Feline Med Surg; 2007 Dec; 9(6):439-45. PubMed ID: 17604205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
